338 related articles for article (PubMed ID: 18996382)
21. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease.
Singh H; Nugent Z; Demers AA; Bernstein CN
Gastroenterology; 2011 Nov; 141(5):1612-20. PubMed ID: 21806945
[TBL] [Abstract][Full Text] [Related]
23. Age at onset of inflammatory bowel disease and the risk of surgery for non-neoplastic bowel disease.
Tremaine WJ; Timmons LJ; Loftus EV; Pardi DS; Sandborn WJ; Harmsen WS; Thapa P; Zinsmeister AR
Aliment Pharmacol Ther; 2007 Jun; 25(12):1435-41. PubMed ID: 17539983
[TBL] [Abstract][Full Text] [Related]
24. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study.
Bernstein CN; Nugent Z; Longobardi T; Blanchard JF
Am J Gastroenterol; 2009 Nov; 104(11):2774-8. PubMed ID: 19623167
[TBL] [Abstract][Full Text] [Related]
25. Effect of oral contraceptives on risk of cervical cancer.
Vanakankovit N; Taneepanichskul S
J Med Assoc Thai; 2008 Jan; 91(1):7-12. PubMed ID: 18386537
[TBL] [Abstract][Full Text] [Related]
26. Infectious gastroenteritis and risk of developing inflammatory bowel disease.
Porter CK; Tribble DR; Aliaga PA; Halvorson HA; Riddle MS
Gastroenterology; 2008 Sep; 135(3):781-6. PubMed ID: 18640117
[TBL] [Abstract][Full Text] [Related]
27. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
Gupta G; Gelfand JM; Lewis JD
Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of inflammatory bowel disease in patients with airways disease.
Raj AA; Birring SS; Green R; Grant A; de Caestecker J; Pavord ID
Respir Med; 2008 May; 102(5):780-5. PubMed ID: 18321696
[TBL] [Abstract][Full Text] [Related]
29. Corticosteroids and the risk of atrial fibrillation.
van der Hooft CS; Heeringa J; Brusselle GG; Hofman A; Witteman JC; Kingma JH; Sturkenboom MC; Stricker BH
Arch Intern Med; 2006 May; 166(9):1016-20. PubMed ID: 16682576
[TBL] [Abstract][Full Text] [Related]
30. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003.
Hutfless SM; Weng X; Liu L; Allison J; Herrinton LJ
Gastroenterology; 2007 Dec; 133(6):1779-86. PubMed ID: 18054550
[TBL] [Abstract][Full Text] [Related]
31. Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study.
Bortoli A; Saibeni S; Tatarella M; Prada A; Beretta L; Rivolta R; Politi P; Ravelli P; Imperiali G; Colombo E; Pera A; Daperno M; Carnovali M; de Franchis R; Vecchi M;
J Gastroenterol Hepatol; 2007 Apr; 22(4):542-9. PubMed ID: 17376049
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
Nørgård B; Pedersen L; Christensen LA; Sørensen HT
Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
[TBL] [Abstract][Full Text] [Related]
33. The relationship between inflammatory bowel disease and socioeconomic variables.
Bernstein CN; Kraut A; Blanchard JF; Rawsthorne P; Yu N; Walld R
Am J Gastroenterol; 2001 Jul; 96(7):2117-25. PubMed ID: 11467642
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
[TBL] [Abstract][Full Text] [Related]
35. Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study.
Kristensen SL; Lindhardsen J; Ahlehoff O; Erichsen R; Lamberts M; Khalid U; Torp-Pedersen C; Nielsen OH; Gislason GH; Hansen PR
Europace; 2014 Apr; 16(4):477-84. PubMed ID: 24108228
[TBL] [Abstract][Full Text] [Related]
36. Psoriasis associated with ulcerative colitis and Crohn's disease.
Cohen AD; Dreiher J; Birkenfeld S
J Eur Acad Dermatol Venereol; 2009 May; 23(5):561-5. PubMed ID: 19207663
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with abnormal Pap results in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Gordon C; Joseph L; Boivin JF; Rajan R; Allen A; Moore AD; Leung MH; Clarke A
Rheumatology (Oxford); 2004 Nov; 43(11):1386-9. PubMed ID: 15280571
[TBL] [Abstract][Full Text] [Related]
38. A population-based case control study of potential risk factors for IBD.
Bernstein CN; Rawsthorne P; Cheang M; Blanchard JF
Am J Gastroenterol; 2006 May; 101(5):993-1002. PubMed ID: 16696783
[TBL] [Abstract][Full Text] [Related]
39. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort.
Ho GT; Chiam P; Drummond H; Loane J; Arnott ID; Satsangi J
Aliment Pharmacol Ther; 2006 Jul; 24(2):319-30. PubMed ID: 16842459
[TBL] [Abstract][Full Text] [Related]
40. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
